These success, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 guidance the thought of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. These benefits counsel that https://davidc391eet4.wikikali.com/user